SOURCE: Equity News Circuit

Equity News Circuit

February 27, 2013 08:15 ET

Free Research Reports on ARWR, RSH, TWI and VVUS Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwire - Feb 27, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Arrowhead Research Corp. (NASDAQ: ARWR) shares surged 6.7 percent on nearly 1.5 million shares traded Tuesday. The company released data that showed its RNAi-based candidate ARC-520 has the potential to treat chronic hepatitis B virus infection, "with the goal of achieving a functional cure."

Find out more about Arrowhead Research including full access to the free equity report at:

RadioShack Corporation (NYSE: RSH) shares traded in the range of $2.70 - $3.24 Tuesday before closing at $3.06 a share. The company reported a net loss of $63 million, or $0.63 per diluted share, compared to a net income of $12 million a year ago. RadioShack ended the year with total liquidity of $926 million.

Find out more about RadioShack including full access to the free equity report at:

Titan International Inc. (NYSE: TWI) shares declined over 15 percent on nearly seven times the average daily volume Tuesday. Despite reporting record sales in the fourth quarter of 2012, the company swung to a loss of $1.1 million in the fourth quarter of 2012, compared to an income of $19.5 million in fourth quarter 2011.

Find out more about Titan International including full access to the free equity report at:

VIVUS, Inc. (NASDAQ: VVUS) shares of the anti-obesity drug maker declined 12.25 percent on more than double the average daily volume Tuesday to close at $10.89 a share. High costs related to commercialization activities for Qsymia saw the company's net loss grow to $56.7 million in the fourth quarter, compared to a net loss of $11.5 million a year ago.

Find out more about VIVUS including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information